Dopamine across timescales and cell types: Relevance for phenotypes in Parkinson's disease progression

被引:0
|
作者
Seiler, Jillian L. [1 ,7 ]
Zhuang, Xiaowen [3 ,5 ,6 ,7 ]
Nelson, Alexandra B. [3 ,4 ,5 ,6 ,7 ,8 ]
Lerner, Talia N. [1 ,2 ,7 ,9 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Neurosci, Chicago, IL USA
[2] Northwestern Univ Interdept Neurosci Program NUIN, Evanston, IL USA
[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
[4] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA USA
[5] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA USA
[6] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA USA
[7] Aligning Sci Parkinsons ASAP Collaborat Res Networ, Chevy Chase, MD USA
[8] UCSF, MC 0663,675 Nelson Rising Lane, San Francisco, CA 94158 USA
[9] Ward 5 120, 303 Chicago Ave, Chicago, IL 60611 USA
关键词
Parkinson's disease; Movement disorders; Neurodegeneration; L-DOPA; Dopamine; Substantia nigra pars compacta; Striatum; Cell types; Heterogeneity; AMINO-ACID DECARBOXYLASE; SUBSTANTIA-NIGRA; EXTRACELLULAR DOPAMINE; NEURONAL VULNERABILITY; INDUCED DYSKINESIA; NMDA-RECEPTORS; 6-OHDA LESIONS; STRIATUM; BRAIN; PLASTICITY;
D O I
10.1016/j.expneurol.2024.114693
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dopamine neurons in the substantia nigra pars compacta (SNc) synthesize and release dopamine, a critical neurotransmitter for movement and learning. SNc dopamine neurons degenerate in Parkinson's Disease (PD), causing a host of motor and non-motor symptoms. Here, we review recent conceptual advances in our basic understanding of the dopamine system - including our rapidly advancing knowledge of dopamine neuron heterogeneity - with special attention to their importance for understanding PD. In PD patients, dopamine neuron degeneration progresses from lateral SNc to medial SNc, suggesting clinically relevant heterogeneity in dopamine neurons. With technical advances in dopamine system interrogation, we can understand the relevance of this heterogeneity for PD progression and harness it to develop new treatments.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Glucocerebrosidase deficiency and dopaminergic cell death: Relevance to Parkinson's disease
    Noelker, C.
    Alvarez-Fischer, D.
    Hoellerhage, M.
    Lu, L.
    Sturn, A.
    Roscher, R.
    Hirsch, E. C.
    Hoeglinger, G. U.
    Hartmann, A.
    MOVEMENT DISORDERS, 2012, 27 : S47 - S47
  • [42] Glucerebrosidase deficiency and dopaminergic cell death: Relevance to Parkinson's disease
    Alvarez-Fischer, D.
    Noelker, C.
    Lu, L.
    Sturn, A.
    Roscher, R.
    Hirsch, E. C.
    Hartmann, A.
    MOVEMENT DISORDERS, 2011, 26 : S13 - S13
  • [43] Microglial responses to dopamine in a cell culture model of Parkinson's disease
    Mastroeni, Diego
    Grover, Andrew
    Leonard, Brian
    Joyce, Jeffrey N.
    Coleman, Paul D.
    Kozik, Brooke
    Bellinger, Denise L.
    Rogers, Joseph
    NEUROBIOLOGY OF AGING, 2009, 30 (11) : 1805 - 1817
  • [44] Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective
    Hagell, P
    Cenci, MA
    BRAIN RESEARCH BULLETIN, 2005, 68 (1-2) : 4 - 15
  • [45] The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease
    Joglar, Belen
    Rodriguez-Pallares, Jannette
    Isabel Rodriguez-Perez, Ana
    Rey, Pablo
    Jose Guerra, Maria
    Luis Labandeira-Garcia, Jose
    JOURNAL OF NEUROCHEMISTRY, 2009, 109 (02) : 656 - 669
  • [46] Comparison of α-dihydroergocryptine and levodopa monotherapy in Parkinson's disease:: Assessment of disease progression with dopamine transporter SPECT
    Tatsch, K
    Poepperl, G
    Ruzicka, E
    Storch, A
    Gasser, T
    Schwarz, J
    MOVEMENT DISORDERS, 2002, 17 : S170 - S170
  • [47] A simple invertebrate model of dopamine-related neurotoxicity: Possible relevance to Parkinson's disease
    Janssen, Shannon
    Marcinkiewcz, Catherine
    Williams, Katrina
    Robinson, Jessica
    Constance, Shannon
    Prokai, David
    Valerio, Holly
    Riley, Jabriel
    Liang, Yanqi
    Shaw, Amanda
    Boules, Mona
    Richelson, Elliott
    Baxter, Lewis R.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S205 - S206
  • [48] Adenosine receptors and Parkinson's disease -: Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum
    Fuxe, K
    Strömberg, I
    Popoli, P
    Rimondini-Giorgini, R
    Torvinen, M
    Ögren, SO
    Franco, R
    Agnati, LF
    Ferré, S
    PARKINSON'S DISEASE, 2001, 86 : 345 - 353
  • [49] Vasoactive intestinal peptide protects from dopamine toxicity: Relevance for Parkinson's disease.
    Melamed, M
    Sharki, J
    Offen, D
    Fridkin, M
    Brenneman, DE
    Gozes, I
    ANNALS OF NEUROLOGY, 1999, 46 (03) : 458 - 459
  • [50] Early stage Parkinson's disease phenotypes
    Toledo, J.
    Rodriguez-Oroz, M. C.
    Ondo, W.
    MOVEMENT DISORDERS, 2018, 33 : S730 - S730